These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Medh RD, Saeed MF, Johnson BH, Thompson EB. Cancer Res; 1998 Aug 15; 58(16):3684-93. PubMed ID: 9721879 [Abstract] [Full Text] [Related]
6. Interactions of the phenylpyrazolo steroid cortivazol with glucocorticoid receptors in steroid-sensitive and -resistant human leukemic cells. Thompson EB, Srivastava D, Johnson BH. Cancer Res; 1989 Apr 15; 49(8 Suppl):2253s-2258s. PubMed ID: 2702665 [Abstract] [Full Text] [Related]
10. Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts. Zhou F, Thompson EB. Mol Endocrinol; 1996 Mar 30; 10(3):306-16. PubMed ID: 8833659 [Abstract] [Full Text] [Related]
11. Two glucocorticoid binding sites on the human glucocorticoid receptor. Srivastava D, Thompson EB. Endocrinology; 1990 Oct 30; 127(4):1770-8. PubMed ID: 2205477 [Abstract] [Full Text] [Related]
13. Glucocorticoid antagonist RU 486 reverses agonist-induced apoptosis and c-myc repression in human leukemic CEM-C7 cells. Thompson EB, Thulasi R, Saeed MF, Johnson BH. Ann N Y Acad Sci; 1995 Jun 12; 761():261-75. PubMed ID: 7625725 [Abstract] [Full Text] [Related]
14. Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells. Thompson EB, Johnson BH. Recent Prog Horm Res; 2003 Jun 12; 58():175-97. PubMed ID: 12795419 [Abstract] [Full Text] [Related]
15. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor. Guo X, Zhou CY, Li Q, Gao J, Zhu YP, Gu L, Ma ZG. Biomed Environ Sci; 2013 May 12; 26(5):371-81. PubMed ID: 23611130 [Abstract] [Full Text] [Related]
17. Glucocorticoid receptors in human leukemias and related diseases. Thompson EB, Smith JR, Bourgeois S, Harmon JM. Klin Wochenschr; 1985 Aug 01; 63(15):689-98. PubMed ID: 2413243 [Abstract] [Full Text] [Related]
19. Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant. Ramos RA, Meilandt WJ, Wang EC, Firestone GL. FASEB J; 1999 Jan 01; 13(1):169-80. PubMed ID: 9872941 [Abstract] [Full Text] [Related]
20. The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor. Yoshikawa N, Yamamoto K, Shimizu N, Yamada S, Morimoto C, Tanaka H. Mol Endocrinol; 2005 May 01; 19(5):1110-24. PubMed ID: 15677712 [Abstract] [Full Text] [Related] Page: [Next] [New Search]